Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-1-19
pubmed:abstractText
We examined the radical-scavenging activity of docosahexaenoic acid (DHA) and its effects on the neuronal cell death induced by oxidative or hypoxic stress in cultured retinal ganglion cells (RGC-5, a rat ganglion cell-line transformed using E1A virus). The radical-scavenging activity [hydrogen peroxide (H(2)O(2)), superoxide anion (O(2)*(-)), and hydroxyl radical (*OH)] of DHA in RGC-5 cells was measured using the ROS-sensitive probes CM-H(2)DCFDA and APF. DHA concentration-dependently scavenged the intracellular radical productions induced by H(2)O(2) radical, O(2)*(-), and *OH (minimum effective DHA concentrations 0.1, 10 and 100 microM, respectively). Cell damage was induced by H(2)O(2), oxygen-glucose deprivation (OGD), or tunicamycin (an endoplasmic reticulum-stress inducer), and cell viability was assessed by Hoechst 33342 nuclear staining or by the tetrazolium salt (WST-8) cell-viability assay. H(2)O(2) (0.3 mM for 24 h), 4-h OGD exposure followed by 18-h reoxygenation, or tunicamycin at 2 microg/ml for 24 h induced apoptotic cell death accompanied by nuclear condensation and/or fragmentation, and each maneuver decreased cell viability. Treatment with DHA at 0.1 and 1 microM significantly inhibited the decrease in cell viability induced by H(2)O(2). Treatment with DHA at 0.1, 1, or 10 microM significantly inhibited the decrease in cell viability induced by OGD/reoxygenation exposure. However, DHA (0.1 to 10 microM) had no effect on the decrease in cell viability induced by tunicamycin. These results indicate that DHA may be protective against oxidative or hypoxic stress-induced cell damage in retinal ganglion cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1872-6240
pubmed:author
pubmed:issnType
Electronic
pubmed:day
28
pubmed:volume
1251
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
269-75
pubmed:meshHeading
pubmed-meshheading:19056360-Animals, pubmed-meshheading:19056360-Anoxia, pubmed-meshheading:19056360-Apoptosis, pubmed-meshheading:19056360-Cell Line, Transformed, pubmed-meshheading:19056360-Cell Survival, pubmed-meshheading:19056360-Cytoprotection, pubmed-meshheading:19056360-Docosahexaenoic Acids, pubmed-meshheading:19056360-Dose-Response Relationship, Drug, pubmed-meshheading:19056360-Free Radical Scavengers, pubmed-meshheading:19056360-Free Radicals, pubmed-meshheading:19056360-Hydrogen Peroxide, pubmed-meshheading:19056360-Ischemia, pubmed-meshheading:19056360-Neuroprotective Agents, pubmed-meshheading:19056360-Oxidative Stress, pubmed-meshheading:19056360-Rats, pubmed-meshheading:19056360-Retinal Ganglion Cells, pubmed-meshheading:19056360-Superoxides, pubmed-meshheading:19056360-Tunicamycin
pubmed:year
2009
pubmed:articleTitle
Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells.
pubmed:affiliation
Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu 502-8585, Japan.
pubmed:publicationType
Journal Article